Status:
COMPLETED
Pre- and Post-TAVI Patient Assessment: Advancing Outcome Precision in Aortic Valve Therapy
Lead Sponsor:
Damanhour University
Collaborating Sponsors:
medina medical center
Tanta University
Conditions:
Aortic Valve Stenosis
Eligibility:
All Genders
50-102 years
Brief Summary
The aim of this study is to evaluate the combined utility of the left atrial coupling index (LACI) and left ventricular speckle tracking echocardiography (LVSTE) in improving risk stratification and o...
Detailed Description
Transcatheter Aortic Valve Implantation (TAVI) has emerged as a transformative procedure for patients with severe aortic stenosis, particularly those at high surgical risk. However, accurately predict...
Eligibility Criteria
Inclusion
- Patients diagnosed with severe aortic stenosis and scheduled for TAVI.
Exclusion
- Patients with significant mitral or tricuspid valve disease requiring intervention.
- History of atrial fibrillation or other arrhythmias that preclude accurate LACI measurement.
- Poor echocardiographic window preventing reliable imaging.
Key Trial Info
Start Date :
February 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07179302
Start Date
February 1 2025
End Date
November 1 2025
Last Update
December 3 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University
Tanta, Gharbia Governorate, Egypt, 31527
2
Medina Medical Center
Madinah, Saudi Arabia